Amphastar Pharmaceuticals, Inc.AMPH

Market cap
$2.4B
P/E ratio
17.5x
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Net income attributable to Amphastar Pharmaceuticals, Inc.-----74716391138
Loss (gain) on disposal of assets------1-0-0-0-0
Gain on deconsolidation of subsidiary-------14--
Impairment of long-lived assets---------3
Gain on interest rate swaps and foreign currency transactions, net--------2-5
Gain on deconsolidation of subsidiary-------14--
Depreciation expense13111213151720222425
Gain on interest rate swaps and foreign currency transactions, net--------2-5
Amortization Of Intangible Assets22332111113
Depreciation expense13111213151720222425
Operating lease right-of-use asset amortization-------344
Amortization Of Intangible Assets22332111113
Equity in losses of unconsolidated affiliate--------0-1-2
Operating lease right-of-use asset amortization-------344
Share-based compensation8121517171720191820
Amortization of Debt Issuance Costs---------11
Changes in reserve for uncertain tax positions-0-000-03121-1
Equity in losses of unconsolidated affiliate--------0-1-2
Changes in deferred taxes, net9-84-41-50-21613
Share-based compensation8121517171720191820
Accounts receivable, net-111-6816-720151026
Inventories-7-1010-19641-15-1122
Prepaid expenses and other assets01-15-142-423
Income tax refunds, deposits, and payable, net---12-4-11-853
Operating lease liabilities------3-4-3-3-4
Accounts payable and accrued liabilities6-3-1729-12213-113
Changes in reserve for uncertain tax positions-0-000-03121-1
Changes in deferred taxes, net9-84-41-50-21613
Accounts receivable, net-111-6816-720151026
Inventories-7-1010-19641-15-1122
Prepaid expenses and other assets01-15-142-423
Income tax refunds, deposits, and payable, net---12-4-11-853
Operating lease liabilities------3-4-3-3-4
Accounts payable and accrued liabilities6-3-1729-12213-113
Net cash provided by operating activities---393842579889184
Purchases and construction of property, plant, and equipment19142135474234272438
BAQSIMI acquisition---------506
Proceeds from the sale of property, plant and equipment-0--0---0-
Purchases and construction of property, plant, and equipment19142135474234272438
Purchase of investments--4609141736145
Proceeds from the sale of property, plant and equipment-0--0---0-
Maturity of investments--340-12192839
Purchase of investments--4609141736145
Payment of deposits and other assets-151-00131-1
Maturity of investments--340-12192839
Net cash used in investing activities----39-42-51-36-29-33-649
Deposits and other assets-151-00131-1
Net cash used in investing activities----39-42-51-36-29-33-649
Acquisition of additional ownership interest in ANP------0---
ANP restructuring (see Note 3)-------54--
ANP restructuring (see Note 3)-------54--
Net proceeds from equity plans-1421149323161611
Net proceeds from equity plans-1421149323161611
Purchase of treasury stock0101031252224294058
Purchase of treasury stock0101031252224294058
Settlement Of Equity Awards--------1--
Settlement Of Equity Awards--------1--
Debt issuance costs-------2025
Debt issuance costs-------2025
Repayments under lines of credit40----0-1--
Proceeds from borrowing under lines of credit25---0-1---
Proceeds from issuance of long-term debt277101984670-845
Repayments under lines of credit40----0-1--
Principal payments on long-term debt891510668372319
Proceeds from issuance of long-term debt277101984670-845
Net cash provided by financing activities----825-4-2-37-26454
Principal payments on long-term debt891510668372319
Net cash provided by financing activities----825-4-2-37-26454
Effect of exchange rate changes on cash------00-0-0-0
Net (decrease) increase in cash, cash equivalents, and restricted cash------13193230-12
Capital Expenditures Incurred but Not yet Paid-----1111954
Deferred Payment For Acquisition---------122
Noncash Operating Lease Right Of Use Asset-----8511211
Capital Expenditures Incurred but Not yet Paid-----1111954
Equipment acquired under finance leases001-00001-
Noncash Operating Lease Right Of Use Asset-----8511211
Equipment acquired under finance leases001-00001-
Interest paid, net of capitalized interest---22222318
Income taxes paid003506384449